• Investors may be wondering whether UFP Technologies, at around US$220 a share, still offers value or whether the strongest period of share price performance is already reflected in the current price.
• The shares have been volatile recently, with the price falling 3.9% over the last week, rising 18.7% over the last month, yet still down 1.5% year to date and 6.0% over the past year, while remaining up 37.7% over three years and 280.9% over five years.
• Recent coverage has focused on UFP Technologies as a medical equipment player with a long track record on the market. That backdrop has helped keep attention on its long term share price performance and provides context for both the pullback over the past year and the sizeable gains over the last three and five years.
• At the moment the company has a 3 out of 6 valuation score. The next step is to break down what different valuation methods indicate about the stock, and then consider a broader perspective on its value that goes beyond any single model.

Approach 1: UFP Technologies Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model projects a company’s future cash flows and then discounts them back to today’s dollars, aiming to estimate what the business may be worth right now.

For UFP Technologies, the model used is a 2 Stage Free Cash Flow to Equity approach. The company’s latest twelve month free cash flow is about $68.6 million. Based on available estimates and extrapolations, free cash flow is projected at $69.6 million in 2026 and $94.5 million in 2027, with further cash flows out to 2035 estimated by Simply Wall St using growth assumptions beyond the explicit analyst period.

Combining these projected cash flows and discounting them back to today results in an estimated intrinsic value of about $356.83 per share. Compared with the recent share price of around $220, this implies a 38.3% discount, which suggests the stock currently screens as undervalued on this DCF view.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests UFP Technologies is undervalued by 38.3%. Track this in your watchlist or portfolio, or discover 46 more high quality undervalued stocks.

Approach 2: UFP Technologies Price vs Earnings

For a profitable company, the P/E ratio is a straightforward way to gauge how much you are paying for each dollar of earnings. It captures what the market is currently willing to pay and is easy to compare across similar stocks.

What counts as a “normal” or “fair” P/E depends on how investors view a company’s growth prospects and risk. Higher expected growth or lower perceived risk can support a higher multiple, while slower growth or higher risk usually leads to a lower one.

UFP Technologies currently trades on a P/E of about 24.8x. That sits close to the Medical Equipment industry average of around 24.2x and below the peer average of roughly 38.0x. Simply Wall St’s Fair Ratio for UFP Technologies is 22.5x, which is its proprietary estimate of what the P/E might be given factors such as earnings growth, profit margins, industry, market cap and risk profile.

The Fair Ratio aims to be more tailored than a simple comparison with peers or the broad industry because it adjusts for company specific characteristics rather than assuming all stocks should trade on the same multiple. Compared with the current 24.8x P/E, the 22.5x Fair Ratio points to UFP Technologies looking slightly overvalued on this metric.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your UFP Technologies Narrative

Earlier it was mentioned that there is an even better way to understand valuation. This is where Narratives come in, giving you a simple story behind your numbers by linking your view of UFP Technologies, your assumptions for future revenue, earnings and margins, and your own fair value into one clear picture.

On Simply Wall St’s Community page, Narratives let you set out why you think the company develops, connect that story to a forecast, then see what fair value those assumptions imply. You can then compare that directly with today’s share price to help decide whether the stock looks appealing or stretched on your terms.

Because Narratives update automatically when new earnings, news or forecasts are added, your view is not static. You can see how your fair value shifts as fresh information comes through.

For UFP Technologies, one investor might build a more optimistic Narrative that lines up with the higher analyst fair value of about US$370.0. Another might prefer a cautious Narrative closer to US$289.0. Comparing those storylines side by side helps you judge which assumptions fit your own expectations before acting.

Do you think there's more to the story for UFP Technologies? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.